Verve Medical today announced the successful treatment of the first patient in a trial of its hypertension treatment.

Verve Medical, the leader in non?invasive renal pelvic denervation (RPD) technology, today announced successful treatment of the first patient in its randomized, double?blinded U.S. pilot clinical ...

The dressing combines several technologies to minimise leakage, reduce dressing changes, and protect vulnerable skin.

In part one of our exclusive gut health series, gastroenterologist Trisha Pasricha identifies the everyday habits throwing ...

Experts highlight the role of primary care in identifying joint hypermobility syndrome and distinguishing it from connective tissue disorders.

Gesynta Pharma AB today announced that the first patient has been dosed in its Phase 2 clinical proof-of-concept trial (NOVA) of vipoglanstat, a novel non-hormonal, non-opioid drug candidate for ...